Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Artery Stenosis Drug Market Size Shifted, And What Is the Outlook Through 2034?
In recent years, the market for artery stenosis drugs has seen considerable growth. It’s projected that its value will increase from $2.47 billion in 2024 to $2.6 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.4%. Factors such as increased prevalence of heart disease, an expanding elderly population, greater understanding about the importance of artery health, expanded use of telemedicine for patient monitoring, and enhancements in healthcare infrastructure have all contributed to the growth experienced in the historical period.
There is set to be significant expansion in the artery stenosis drug market in the coming years, with its size projected to reach $3.27 billion in 2029, at a compound annual growth rate (CAGR) of 5.9%. The anticipated growth within this period can be credited to factors such as the rising prevalence of obesity and diabetes, an increased interest in minimally invasive procedures, improvements in healthcare accessibility in developing markets, growing healthcare costs, and an increase in diabetes and obesity occurrences. Key trends projected within this same period comprise personalized medication strategies, greater usage of combination therapies, improved diagnostic procedures, elevated emphasis on preventive cardiology, and the creation of innovative drug distribution systems.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24151&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Artery Stenosis Drug Market?
The surge in cases of diabetes and obesity is predicted to boost the expansion of the artery stenosis drug market. Diabetes, a chronic illness characterized by inadequate insulin production or malfunctioning insulin utilization, leads to high blood sugar levels. In comparison, obesity is defined by an overabundance of body fat, escalating the possibility of multiple health problems. The surge in these conditions can be attributed to a lack of consistent physical exercise, linked with increasingly stationary work surroundings and screen-based hobbies, aiding weight increase and insulin resistance. Drugs for artery stenosis are essential for those with diabetes and obesity, as these ailments encourage plaque accumulation in the arteries, thereby escalating the potential for heart attacks and strokes. For example, the World Health Organization, a UN-affiliated agency based in Switzerland, reported in March 2024 that in 2022, there were 2.5 billion adults who were overweight, including 890 million living with obesity. Hence, the escalating incidences of diabetes and obesity are stimulating growth in the artery stenosis drug market.
Which Key Market Segments Comprise the Artery Stenosis Drug Market and Drive Its Revenue Growth?
The artery stenosis drug market covered in this report is segmented –
1) By Drug Type: Antiplatelet Agents, Anticoagulants, Statins, Beta Blockers
2) By Mechanism Of Action: Platelet Aggregation Inhibitors, Thrombin Inhibitors, HMG-CoA Reductase Inhibitors, Beta-Adrenergic Antagonists
3) By Route Of Administration: Oral, Injectable, Transdermal
4) By Patient Type: Adults, Geriatric, Pediatric
Subsegments:
1) By Antiplatelet Agents: Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dipyridamole
2) By Anticoagulants: Warfarin, Heparin, Low Molecular Weight Heparins, Direct Oral Anticoagulants (DOACs)
3) By Statins: Atorvastatin, Simvastatin, Rosuvastatin, Pravastatin, Lovastatin
4) By Beta Blockers: Metoprolol, Atenolol, Propranolol, Carvedilol, Bisoprolol
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24151&type=smp
Which Areas Are Leading Regions in the Artery Stenosis Drug Market Expansion Across the Globe?
North America was the largest region in the artery stenosis drug market in 2024. The regions covered in the artery stenosis drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theArtery Stenosis Drug Market Direction?
Leading businesses in the artery stenosis drug market are concentrating their efforts on progressing therapeutic solutions like bempedoic acid to meet the medical requirements that aren’t being addressed in the hypercholesterolemia treatment area. This ground-breaking drug, bempedoic acid, is built to reduce LDL cholesterol levels in patients who either can’t tolerate statins or require further lipid-lowering treatment. As an illustration, Zydus Lifesciences Ltd., which is a pharmaceutical corporation based in India, introduced Bemdac, an innovative oral treatment for hypercholesterolemia, in India in May 2022. Bemdac includes bempedoic acid, pioneering its class of drugs, developed to decrease LDL cholesterol levels in patients who have an intolerance to statins or need additional lipid-lowering treatment. The introduction of this product is intended to bring forth a novel treatment choice that enhances cardiovascular results by focusing on cholesterol synthesis within the liver whilst minimizing muscle-related side effects usually associated with the use of statins.
View the full report here:
https://www.thebusinessresearchcompany.com/report/artery-stenosis-drug-global-market-report
How Is the Artery Stenosis Drug Market Conceptually Defined?
Artery stenosis drugs are medications used to manage and treat the narrowing of arteries, a condition known as stenosis, which can lead to reduced blood flow and associated health complications. These drugs aim to alleviate symptoms, prevent progression, and reduce the risk of serious events such as heart attacks or strokes.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24151
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
